FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely urology, namely to a method for preventing and treating benign prostatic hyperplasia (BPH). The method for preventing and treating benign prostatic hyperplasia in males involves administering an agent based on a pro-vitamin pine concentrate.
EFFECT: method is effective for preventing and treating benign prostatic hyperplasia in males.
5 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD AND REMEDY FOR TREATMENT AND PREVENTION OF BENIGN PROSTATIC HYPERPLASIA | 2019 |
|
RU2764850C1 |
| METHOD FOR INTERMITTENT THERAPY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA | 2013 |
|
RU2531944C1 |
| METHOD OF TREATING PROSTATE ADENOMA COMBINED WITH CHRONIC NONBACTERIAL PROSTATITIS | 2014 |
|
RU2568369C1 |
| ANTIPROLIFERATIVE AGENT | 2011 |
|
RU2519727C2 |
| ANTIPROLIFERATIVE AGENT | 2012 |
|
RU2482857C1 |
| MEDICATION (VERSIONS), PHARMACEUTICAL COMPOSITION AND METHOD OF CHEMOPROPHYLAXIS OF PROSTATE PRE-CANCER AND CANCER | 2012 |
|
RU2571818C2 |
| LOW-TOXIC 1,3,4-OXADIAZOLE DERIVATIVES OF DEOXYCHOLIC ACID WITH PROSTATE-PROTECTIVE AND ANTI-INFLAMMATORY ACTION | 2023 |
|
RU2819604C1 |
| 1,2,4-OXADIAZOLE DERIVATIVES OF DESOXYCHOLIC ACID, EXHIBITING PROSTATE-PROTECTIVE EFFECT, HYPOCHOLESTEROLEMIC AND ANTI-INFLAMMATORY ACTIVITY | 2020 |
|
RU2750488C1 |
| METHOD FOR COMBINATION THERAPY OF BENIGN PROSTATIC HYPERPLASIA OF LARGE DIMENSIONS IN AGED PATIENTS OR PATIENTS WITH MARKED INTERCURRENT PATHOLOGY | 2015 |
|
RU2585431C1 |
| METHOD FOR DETERMINATION OF TREATMENT STRATEGY FOR LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA AGAINST THE BACKGROUND OF TESTOSTERONE DEFICIENCY | 2022 |
|
RU2795840C1 |
